journal
Journals Clinical Gastroenterology and ...

Clinical Gastroenterology and Hepatology

https://read.qxmd.com/read/38367742/association-between-celiac-disease-and-irritable-bowel-syndrome-a-nationwide-cohort-study
#41
JOURNAL ARTICLE
Karl Mårild, Jonas Söderling, Benjamin Lebwohl, Peter Hr Green, Hans Törnblom, Magnus Simrén, Kyle Staller, Ola Olén, Jonas F Ludvigsson
BACKGROUND & AIMS: To determine the risk of irritable bowel syndrome (IBS) diagnosis in patients with celiac disease (CD) compared to general population comparators. METHODS: Using Swedish histopathology and register-based data, we identified 27,262 patients with CD diagnosed in 2002-2017 and 132,922 age- and sex-matched general population comparators. Diagnoses of IBS were obtained from nationwide inpatient and non-primary outpatient records. Cox regression estimated hazard ratios (aHRs) for IBS adjusted for education level and Charlson Comorbidity Index...
February 15, 2024: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/38367741/choosing-a-comparator-minimizing-baseline-differences-between-groups
#42
LETTER
Mary Andrews, Shirin Hemmat, Tram T Tran
No abstract text is available yet for this article.
February 15, 2024: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/38367740/prescribing-of-proton-pump-inhibitors-for-prevention-of-upper-gastrointestinal-bleeding-in-u-s-outpatient-visits
#43
JOURNAL ARTICLE
Jacob E Kurlander, John N Mafi, Michael J Racz, Geoffrey D Barnes, Sameer D Saini, Patrick D Meek, Elliot B Tapper, Jeffrey T Kullgren, Joel H Rubenstein, Caroline R Richardson, Danielle Helminski
No abstract text is available yet for this article.
February 15, 2024: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/38365095/multi-level-interventions-to-improve-colorectal-cancer-screening-in-an-urban-native-american-community-a-pilot-randomized-clinical-trial
#44
JOURNAL ARTICLE
Aasma Shaukat, Jack Wolf, Kyle Ryder, Jennifer P Wisdom, Timothy R Church
No abstract text is available yet for this article.
February 14, 2024: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/38365094/chronic-viral-hepatitis-b-and-c-outweigh-masld-in-the-associated-risk-of-cirrhosis-and-hcc
#45
JOURNAL ARTICLE
Mei-Hsuan Lee, Yi-Ting Chen, Yu-Han Huang, Sheng-Nan Lu, Tsai-Hsuan Yang, Jee-Fu Huang, Szu-Ching Yin, Ming-Lun Yeh, Chung-Feng Huang, Chia-Yen Dai, Wan-Long Chuang, Ming-Lung Yu, Hwai-I Yang, Hsuan-Yu Chen, Chien-Jen Chen
BACKGROUND AND AIMS: The impact of metabolic dysfunction-associated steatotic liver disease (MASLD) on the development of cirrhosis and hepatocellular carcinoma (HCC) by chronic hepatitis B (CHB) or C infection and antiviral treatment statuses is not well known. METHODS: A total of 336,866 adults aged ≥30 years were prospectively enrolled in a health screening program between 1997-2013. MASLD was identified by abdominal ultrasonography and cardiometabolic profiles...
February 14, 2024: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/38365093/assessment-and-significance-of-histologic-activity-in-crohn-disease
#46
EDITORIAL
Alexandros D Polydorides
No abstract text is available yet for this article.
February 14, 2024: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/38354970/association-between-vonoprazan-and-the-risk-of-gastric-cancer-after-helicobacter-pylori-eradication
#47
JOURNAL ARTICLE
Junya Arai, Atsushi Miyawaki, Tomonori Aoki, Ryota Niikura, Yoku Hayakawa, Hiroaki Fujiwara, Sozaburo Ihara, Mitsuhiro Fujishiro, Masato Kasuga
BACKGROUND AND AIMS: Potassium-competitive acid blockers (PCABs) have been increasingly used to treat upper gastrointestinal disorders, replacing proton pump inhibitors (PPIs). While PPIs are associated with an increased risk of gastric cancer (GC) after Helicobacter pylori (Hp) eradication, it is uncertain whether PCABs carry the same risk. METHODS: Using a population-based claims database in Japan, we identified patients who were prescribed a clarithromycin-based first regimen of Hp eradication between 2015 and 2018...
February 12, 2024: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/38354969/hypercholesterolemia-is-associated-with-dysregulation-of-lipid-metabolism-and-poor-prognosis-in-primary-biliary-cholangitis
#48
JOURNAL ARTICLE
Linhua Zheng, Siyuan Tian, Chunmei Yang, Bo Li, Gui Jia, Yansheng Liu, Ruiqing Sun, Xiufang Wang, Juan Deng, Miao Zhang, Lina Cui, Changcun Guo, Xinmin Zhou, Patrick S C Leung, Christopher L Bowlus, M Eric Gershwin, Yulong Shang, Ying Han
BACKGROUND AND AIMS: Hypercholesterolemia is frequently diagnosed in patients with primary biliary cholangitis (PBC). However, its association with the prognosis and lipid metabolism is unknown. In this study, we aimed to investigate the prognostic value of baseline total cholesterol (TC) levels in PBC and characterized the lipid metabolism. METHODS: Of note, 531 patients with PBC without prior cirrhosis-related complications were randomly divided into the derivation and validation cohorts at a ratio of 7:3...
February 12, 2024: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/38346569/dissecting-geographical-and-racial-disparities-in-h-pylori-infection-rates-screening-and-eradication-strategies-in-the-u-s
#49
LETTER
Yasutoshi Shiratori, Naoki Ishii, Anthony Kalloo
No abstract text is available yet for this article.
February 10, 2024: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/38346568/steatotic-liver-disease-advancing-science-and-patient-care-beyond-traditions
#50
LETTER
Markos Kalligeros, Eleftherios Mylonakis, Mazen Noureddin
No abstract text is available yet for this article.
February 10, 2024: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/38342276/glucagon-like-peptide-1-receptor-agonists-in-patients-with-cirrhosis-answering-the-unanswered-questions
#51
EDITORIAL
Sara Mahgoub, Philip N Newsome
No abstract text is available yet for this article.
February 10, 2024: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/38342277/feasibility-and-colonoscopy-yield-using-the-fecal-immunochemical-test-fit-based-colorectal-screening-in-a-latin-america-country
#52
JOURNAL ARTICLE
Mauricio Paulin Sorbello, Ulysses Ribeiro Júnior, José Eluf-Neto, Vinicius Pfuetzenreiter, Afonso da Silva E Sousa, Fábio Shiguehissa Kawaguti, Diane Dede Cohen, Evandro Sobroza de Mello, Sergio Carlos Nahas, Adriana Vaz Safatle-Ribeiro
BACKGROUND AND AIMS: Organized colorectal cancer (CRC) is not widely practiced in Latin America and the results of regional studies may help overcome barriers for implementation of national screening programs. We aimed to describe the implementation and findings of a fecal immunochemical test (FIT)-based program in Brazil. METHODS: In a prospective population-based study, asymptomatic individuals (50 to 75 years-old) from Sao Paulo city were invited to undergo FIT for CRC screening...
February 9, 2024: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/38342275/from-chatgpt-to-gutgpt-enhancing-ai-for-personalized-healthcare
#53
LETTER
Qingzhou Kong, Yueyue Li, Yanqing Li
No abstract text is available yet for this article.
February 9, 2024: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/38325602/gastric-malignancies-in-united-states-in-the-period-from-2000-to-2018
#54
LETTER
Helge L Waldum
No abstract text is available yet for this article.
February 6, 2024: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/38325601/low-colorectal-cancer-risk-after-resection-of-high-risk-pedunculated-polyps
#55
JOURNAL ARTICLE
Manuel Zorzi, Jessica Battagello, Claudio Barbiellini Amidei, Giulio Antonelli, Bastianello Germanà, Flavio Valiante, Stefano Benvenuti, Alberto Tringali, Francesco Bortoluzzi, Erica Cervellin, Davide Giacomin, Tamara Meggiato, Erik Rosa Rizzotto, Diego Fregonese, Manuela D'Incà, Gianluca Baldassarre, Paola Scalon, Maurizio Pantalena, Luisa Milan, Gianmarco Bulighin, Daniele Di Piramo, Maurizio Azzurro, Armando Gabbrielli, Alessandro Repici, Massimo Rugge, Cesare Hassan
BACKGROUND: Post-fecal immunochemical test (FIT) colonoscopy represents a setting with an enriched prevalence of advanced adenomas. Due to an expected higher risk of colorectal cancer (CRC), postpolypectomy surveillance is recommended, generating a substantially increased load on endoscopy services. The aim of our study was to investigate postpolypectomy CRC risk in a screening population of FIT+ subjects after resection of low-risk adenomas (LRAs) or high-risk adenomas (HRAs). METHODS: We retrieved data from a cohort of patients undergoing postpolypectomy surveillance within a FIT-based CRC screening program in Italy between 2002 and 2017 and followed-up to December 2021...
February 5, 2024: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/38325600/pathogenic-variant-ipmn-tumors-show-increased-tumor-growth-compared-to-those-with-familial-pancreatic-cancer-kindreds-prognostic-indicators
#56
LETTER
Mitchell S Cappell, Martin Tobi
No abstract text is available yet for this article.
February 5, 2024: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/38320680/the-janus-faced-nature-of-sld-in-chronic-hepatitis-b
#57
LETTER
Shang-Chin Huang, Tung-Hung Su, Jia-Horng Kao
No abstract text is available yet for this article.
February 4, 2024: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/38320679/biomarkers-for-personalizing-ibd-therapy-the-quest-continues
#58
REVIEW
Raja Atreya, Markus F Neurath
Despite recent advances in the understanding of the pathogenesis of inflammatory bowel diseases (IBD) and advent of multiple targeted therapies, approximately one-third of patients are primary non-responders to initiated treatment, and half of patients lose response over time. There is currently a lack of available biomarkers that would prognosticate therapeutic effectiveness of these advanced therapies. This is partly explained by insufficient characterization of the functional roles assumed by the chosen molecular targets during disease treatment...
February 4, 2024: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/38311149/reply-to-li-et-al
#59
LETTER
Rohit Loomba, Mohammad Zamani
No abstract text is available yet for this article.
February 2, 2024: Clinical Gastroenterology and Hepatology
https://read.qxmd.com/read/38311148/scrutinizing-chatgpt-applications-in-gastroenterology-a-call-for-methodological-rigor-to-define-accuracy-and-preserve-privacy
#60
LETTER
Mauro Giuffrè, Dennis L Shung
No abstract text is available yet for this article.
February 2, 2024: Clinical Gastroenterology and Hepatology
journal
journal
20073
3
4
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.